20-Mar-2026
No headlines found.
Accendra Health Reports Fourth Quarter 2025 Financial Results
Business Wire (Thu, 19-Feb 4:05 PM ET)
Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call
Business Wire (Thu, 5-Feb 4:05 PM ET)
Accendra Health, Inc. to Begin Trading on NYSE under New Ticker "ACH"
Business Wire (Fri, 2-Jan 6:30 AM ET)
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
Accendra Health trades on the NYSE stock market under the symbol ACH.
As of March 20, 2026, ACH stock price declined to $1.96 with 2,220,494 million shares trading.
ACH has a market cap of $149.82 million. This is considered a Micro Cap stock.
Last quarter Accendra Health reported $709 million in Revenue and $.21 earnings per share. This fell short of revenue expectation by $-8 million and missed earnings estimates by -$.01.
The top ETF exchange traded funds that ACH belongs to (by Net Assets): FNDA, VTI, IWM, VXF, IWN.
ACH support price is $1.92 and resistance is $2.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACH shares will trade within this expected range on the day.